Bridgepoint Group

We’re delighted to have won Nordic Deal of the Year at the Real Deals Private Equity Awards for Vitamin Well Group, a leading functional food and beverage business based in Sweden.   The award recognises the successful realisation of our investments in the company, where we partnered with the team to accelerate international growth, expand its brand portfolio and drive digital and direct-to-consumer capabilities. The business grew revenue twelvefold during the partnership and strengthened its position across key markets in Europe and the US.   A great example of teams across the Bridgepoint platform supporting a company throughout its growth journey, attracting investment from Bridgepoint Development Capital in 2016 before further investment from Bridgepoint Europe in 2021.    Well done to those involved through the years, including Johan Dahlfors | Christopher Bley | Lina Sadovskaja | Martin J. | Johan Gustafsson | Benoit Alteirac   Congratulations also to all our peers who were recognised – and thank you to Real Deals for the great evening! 

Great to be back at Paddington Academy for its Employability Day, where volunteers from our London office spent the morning helping students prepare for upcoming local work experience placements with 1-on-1 mock interviews.   Colleagues from our Credit and Investor Relations teams shared practical tips, encouragement and feedback, providing many of the students with their first experience of an interview – in which they did a fantastic job!    We’re proud to continue our partnership with Paddington Academy, helping to equip students with skills and confidence for the future. With thanks to the PA team and our volunteers: Katie Cotterell | Charlie Huntingford | Dessy D | Karishma Maini | Namita Soni | Nigela Houghton

Since partnering with Achilles Information Limited in 2021, Bridgepoint has supported the business in scaling its global supply chain risk management platform, investing in technology and accelerating its M&A strategy. Now active in 22 countries, Achilles continues to grow, with the recent addition of GRMS | Global Risk Management Solutions marking an important step in expanding its presence in the key North American market. Speaking to Mergermarket recently, Matt Legg, Partner at Bridgepoint, and Dr. Paul Stanley FRSA FIoD AFRIN, CEO at Achilles, shared more on what’s driving that momentum – and how Bridgepoint is helping to deliver it. 🗨️ Achilles has the financial support from Bridgepoint to fund the “right acquisition”, said Legg, alongside wider resources and deep sector expertise, drawing from Bridgepoint’s extensive track record of scaling services businesses internationally. 🗨️ Further acquisitions are planned, said Stanley, with a focus on strategic targets that can help build strength and add depth to Achilles’ offering. Read the full interview here 👉 https://lnkd.in/ebdv89gW

Exciting progress from Aiviq, part of the Alpha FMC group, as we support a significant new investment in their artificial intelligence initiatives for the asset management industry. As a growth investor, Bridgepoint is backing Alpha and AIVIQ to accelerate their expansion and innovation – helping asset and wealth managers harness data to drive performance and unlock new opportunities. Charles Welham | Davina Sladden | Carsten Kratz | Angus Neilson

Stephen Escudier and Rohit Dhote recently sat down with Private Debt Investor to talk through the evolution of Bridgepoint's Credit Opportunities strategy. Noting the strategy’s flexible mandate, deep sourcing capabilities and differentiated return profile, they outlined how Bridgepoint continues to capture opportunities in times of market dislocation, with a particular focus on exploring exciting areas like the €1.3 trillion asset-based finance market. As Stephen notes, “If you can generate average returns in the low to mid-teens over 15 years and then outperform in periods of economic uncertainty, it’s an extremely compelling investment opportunity.” Read the full interview here: https://lnkd.in/gAzhATiJ

Great to see Kyriba featured in L'AGEFI – a testament to the strength of its platform, growth prospects and standout leadership.   Since our initial investment in 2019, Kyriba has scaled to over €300m in revenue, with a clear path ahead as it expands in key markets globally, develops state-of-the-art products and continues to lead the market in liquidity management software.   We’re proud to be part of this journey! David Nicault | Baptiste Fournier | Chris Devereux | Gabor P. | Jacob Ast | William Sihver | Annick Isabel Swinka

Great news from our portfolio! Laboratoires Vivacy has joined forces with Burgeon Biotechnology - the team behind NOVUMA, a cutting-edge biostimulator that boosts natural collagen production. This deal brings together Vivacy’s expertise in hyaluronic acid with Burgeon’s innovative calcium hydroxyapatite-based tech, marking an exciting entry into the biostimulants space. A strong match, and a great move for the regenerative aesthetics market 👏 Vincent Gael BAUDET | Fabrice Turcq | Anne-Sophie Moinade | Astrid Legoux, CFA

Earlier this month, our Chief Investment Officer Xavier Robert sat down with Melissa Di Donato, Chair and CEO of Kyriba, for a candid conversation to mark International Women’s Day. From embracing risk to making tough decisions, Melissa shared advice on navigating careers not as a straight ladder but more like a New York City fire escape – with sideways steps sometimes required to make the biggest leaps forward. We loved this analogy! On leadership and culture, Xavier and Melissa reflected on how men have at least as important a role as women when it comes to driving progress in the workplace.

At the recent Women’s Private Equity Summit, hosted by With Intelligence, Bridgepoint’s Head of Sectors Emma Watford joined a panel discussion exploring a critical question: where can international investors find the best opportunities in 2025?   In the session, Emma shared her insights on why Europe’s mid-market remains a compelling investment opportunity, particularly in an environment of economic uncertainty and shifting global dynamics. With strong sector fundamentals and a deep pool of high-quality businesses, the region remains a key destination for capital deployment.

With food security becoming an increasingly important global challenge, the agricultural sciences sector is undergoing a major transformation. At Bridgepoint, we’ve built a longstanding track record as an early mover with deep sector expertise in this space, creating an ecosystem of leading businesses at the forefront of innovation. Our focus? Plant genetics, biological solutions and value-add services – critical areas driving higher yields, more sustainable farming practices and healthier food production. Carlos Sanz and Rupprecht Pranckh recently sat down with Agri Investor to discuss Bridgepoint’s portfolio strategy in this space, built on complementary investments that not only create real synergies for customers across the agri-tech value chain, but which also deliver robust growth and attractive financial returns. Our present portfolio includes: 🌍 Rovensa – the global leader in biological crop solutions, helping farmers transition to sustainable agriculture 🌱 Meristem Crop Performance – a fast-growing supplier of bio solutions, driving innovation in crop inputs 🍇 Sun World International – pioneering advanced fruit genetics to develop high-yield, climate-resilient crops 💬 According to Rupprecht, "Many investors are very interested in the theme, not just because of the impact it brings, but also because we’ve demonstrated very good and very consistent returns”. 📖 Read the full interview here: https://lnkd.in/eQAzFiaF